Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo

id	metarevistapublica_fucsalud_revistarepertoriodemedicinaycirugia_98-article-1040
record_format	ojs
spelling	Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo Reyna Villasmil, Eduardo Artículo de revista Núm. 3 , Año 2021 : Septiembre - Diciembre 3 30 Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud Revista Repertorio de Medicina y Cirugía Fernández-Ramírez , Andreina Mejia-Montilla, Jorly Torres-Cepeda, Duly Reyna-Villasmil, Nadia Journal article Cheewakriangkrai C, Srisomboon J, Chitapanarux I, Suprasert P, Phongnarisorn C, Siriaree S, Charoenkwan K. Concurrent cisplatin-based chemoradiation and adjuvant hysterectomy for bulky stage IB-IIA cervical cancer. J Med Assoc Thai. 2005;88(10):1331-7. Datta NR, Stutz E, Liu M, Rogers S, Klingbiel D, Siebenhüner A, Singh S, Bodis S. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis. Gynecol Oncol. 2017;145(2):374-385. doi: 10.1016/j.ygyno.2017.01.033. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22(5):872-80. Matsuo K, Shimada M, Aoki Y, Sakamoto M, Takeshima N, Fujiwara H, Matsumoto T, Mikami M, Sugiyama T. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation. Int J Cancer. 2017;141(5):1042-1051. doi: 10.1002/ijc.30793. Liu JL, Huang WS, Lee KC, Tung SY, Chen CN, Chang SF. Effect of 5-fluorouracil on excision repair cross-complementing 1 expression and consequent cytotoxicity regulation in human gastric cancer cells. J Cell Biochem. 2018;119(10):8472-8480. doi: 10.1002/jcb.27073. Valdes G, Iwamoto KS. Re-evaluation of cellular radiosensitization by 5-fluorouracil: high-dose, pulsed administration is effective and preferable to conventional low-dose, chronic administration. Int J Radiat Biol. 2013;89(10):851-62. doi: 10.3109/09553002.2013.797620. Sartori E, Tisi G, Chiudinelli F, La Face B, Franzini R, Pecorelli S. Early stage cervical cancer: adjuvant treatment in negative lymph node cases. Gynecol Oncol. 2007;107(1 Suppl 1):S170-4. doi: 10.1016/j.ygyno.2007.07.026 Stehman FB, Ali S, Keys HM, Muderspach LI, Chafe WE, Gallup DG, Walker JL, Gersell D. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol. 2007;197(5):503.e1-6. doi: 10.1016/j.ajog.2007.08.003 Lee JW, Kim BG, Lee SJ, Lee SH, Park CS, Lee JH, Huh SJ, Bae DS. Preliminary results of consolidation chemotherapy following concurrent chemoradiation after radical surgery in high-risk early-stage carcinoma of the uterine cervix. Clin Oncol (R Coll Radiol). 2005;17(6):412-7. doi: 10.1016/j.clon.2005.02.006 Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65(1):169-76. Reichert ZR, Wahl DR, Morgan MA. Translation of targeted radiation sensitizers into clinical trials. Semin Radiat Oncol. 2016;26(4):261-70. doi: 10.1016/j.semradonc.2016.06.001. Mabuchi S, Morishige K, Isohashi F, Yoshioka Y, Takeda T, Yamamoto T, Yoshino K, Enomoto T, Inoue T, Kimura T. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol. 2009;115(3):482-7. doi: 10.1016/j.ygyno.2009.09.002. Rushdan MN, Tay EH, Khoo-Tan HS, Lee KM, Low JH, Ho TH, Yam KL. Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study. Ann Acad Med Singapore. 2004;33(4):467-72. Petrelli F, De Stefani A, Raspagliesi F, Lorusso D, Barni S. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2014;134(1):166-71. doi: 10.1016/j.ygyno.2014.04.049. https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/2036 Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. Cochrane Database Syst Rev. 2014;(12):CD010401. doi: 10.1002/14651858.CD010401.pub2. http://purl.org/coar/resource_type/c_2df8fbb1 Text http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/publishedVersion http://purl.org/redcol/resource_type/ART http://purl.org/coar/resource_type/c_6501 Monk BJ, Wang J, Im S, Stock RJ, Peters WA 3rd, Liu PY, Barrett RJ 2nd, Berek JS, Souhami L, Grigsby PW, Gordon W Jr, Alberts DS; Gynecologic Oncology Group; Southwest Oncology Group; Radiation Therapy Oncology Group. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96(3):721-8. doi: 10.1016/j.ygyno.2004.11.007 info:eu-repo/semantics/article https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/2037 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1841 Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Eur J Cancer Care (Engl). 2008;17(2):174-81. doi: 10.1111/j.1365-2354.2007.00831.x. https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1787 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1786 Chen L, Lü WG, Xie X, Chen HZ, Yu H, Ni XH. Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa. Zhonghua Fu Chan Ke Za Zhi. 2005;40(4):239-42. Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D, Alemán A, Torrella A, Chico M, Vicente M, Díaz JM, Larrañaga N, Marcos-Gragera R, Sánchez MJ, Perucha J, Franch P, Navarro C, Ardanaz E, Bigorra J, Rodrigo P, Bonet RP; REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017;19(7):799-825. doi: 10.1007/s12094-016-1607-9. Sakakibara A, Matsui K, Katayama T, Higuchi T, Terakawa K, Konishi I. Age-related survival disparity in stage IB and IIB cervical cancer patients. J Obstet Gynaecol Res. 2019;45(3):686-694. doi: 10.1111/jog.13891. text/xml cáncer de cuello uterino radioterapia 5-fluorouracilo cisplatino cervical cancer radiotherapy 5-fluorouracil cisplatin 2021-11-11 00:00:00 2021-11-11 00:00:00 2021-11-11 application/pdf text/html application/epub+zip audio/mpeg Trudel M, Merlot B, Dedet B, Faye N, Kerdraon O, Vinatier D, Collinet P. Is radical hysterectomy necessary in surgical procedure for early stage cervical cancer? Gynecol Obstet Fertil. 2013;41(12):715-21. doi: 10.1016/j.gyobfe.2013.10.002. Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Brambs CE, Höhn AK, Hentschel B, Fischer U, Bilek K, Horn LC. The prognostic impact of grading in FIGO IB and IIB squamous cell cervical carcinomas. Geburtshilfe Frauenheilkd. 2019;79(2):198-204. doi: 10.1055/a-0828-7681. Fregnani JH, de Oliveira Latorre Mdo R, Novik PR, Lopes A, de Oliveira JC, Tsunoda AT, Soares FA. Extent of pelvic lymphadenectomy in women with squamous cell carcinoma of the uterine cervix: is there any prognostic value? J Surg Oncol. 2009;100(3):252-7. doi: 10.1002/jso.21252. Kokka F, Bryant A, Brockbank E, Powell M, Oram D. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev. 2015;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688. 8 1 Revista Repertorio de Medicina y Cirugía - 2021 0121-7372 https://creativecommons.org/licenses/by-nc-sa/4.0 https://doi.org/10.31260/RepertMedCir.01217372.1040 10.31260/RepertMedCir.01217372.1040 https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1040 2462-991X Publication
institution	FUNDACIÓN UNIVERSITARIA DE CIENCIA DE LA SALUD
thumbnail	https://nuevo.metarevistas.org/FUNDACIONUNIVERSITARIADECIENCIADELASALUD/logo.png
country_str	Colombia
collection	Revista Repertorio de Medicina y Cirugía
title	Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
spellingShingle	Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo Reyna Villasmil, Eduardo Fernández-Ramírez , Andreina Mejia-Montilla, Jorly Torres-Cepeda, Duly Reyna-Villasmil, Nadia cáncer de cuello uterino radioterapia 5-fluorouracilo cisplatino cervical cancer radiotherapy 5-fluorouracil cisplatin
title_short	Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
title_full	Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
title_fullStr	Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
title_full_unstemmed	Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
title_sort	radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
author	Reyna Villasmil, Eduardo Fernández-Ramírez , Andreina Mejia-Montilla, Jorly Torres-Cepeda, Duly Reyna-Villasmil, Nadia
author_facet	Reyna Villasmil, Eduardo Fernández-Ramírez , Andreina Mejia-Montilla, Jorly Torres-Cepeda, Duly Reyna-Villasmil, Nadia
topic	cáncer de cuello uterino radioterapia 5-fluorouracilo cisplatino cervical cancer radiotherapy 5-fluorouracil cisplatin
topic_facet	cáncer de cuello uterino radioterapia 5-fluorouracilo cisplatino cervical cancer radiotherapy 5-fluorouracil cisplatin
citationvolume	30
citationissue	3
citationedition	Núm. 3 , Año 2021 : Septiembre - Diciembre
publisher	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
ispartofjournal	Revista Repertorio de Medicina y Cirugía
source	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1040
language
format	Article
rights	http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Revista Repertorio de Medicina y Cirugía - 2021 https://creativecommons.org/licenses/by-nc-sa/4.0
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_2df8fbb1
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2021-11-11
date_accessioned	2021-11-11 00:00:00
date_available	2021-11-11 00:00:00
url	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1040
url_doi	https://doi.org/10.31260/RepertMedCir.01217372.1040
issn	0121-7372
eissn	2462-991X
doi	10.31260/RepertMedCir.01217372.1040
citationstartpage	1
citationendpage	8
url5_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/2036
url7_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/2037
url4_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1841
url3_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1787
url2_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1786
_version_	1829538338510471168

Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo .

Código QR

Estadísticas y Métricas Alternativas

Títulos similares

Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
.